Literature DB >> 17306621

Oxidative remodeling in pressure overload induced chronic heart failure.

Brooke C Henderson1, Neetu Tyagi, Alexander Ovechkin, Ganesh K Kartha, Karni S Moshal, Suresh C Tyagi.   

Abstract

Despite extensive strides in understanding pressure overload induced heart failure, there is very little known about oxidative stress induced matrix metalloproteinase (MMP) activation, collagen degradation and remodeling in pressure overload heart failure. We hypothesize that pressure overload leads to redox imbalance causing increased expression/activity of MMP-2/9 producing collagen degradation and heart failure. To test this hypothesis, we created pressure overload heart failure by abdominal aortic stenosis (AS) in wild-type C57BL/6J and collagen mutant (Col1a1 with 129 s background) mice. At 4 weeks, post surgery, functional parameters were measured. Left ventricle (LV) tissue sections were analyzed by histology, Western Blot and PCR. The results suggest an increase in iNOS with a decrease in eNOS, an increase in nitrated protein modification and depletion of antioxidants thioredoxin and SOD in pressure overload. MMP-2/9 expression/activity and collagen degradation were increased in the AS animals. To determine whether a mutation in the collagen gene at the site of MMP cleavage mitigates cardiac hypertrophy, we used Col1a1 mice. In these mice, the AS induced LV hypertrophy (LVH) was ameliorated. In conclusion, our results suggest that AS leads to increased oxidative stress, expression/activity of MMP-2/9 and a decrease in antioxidant expression producing collagen degradation and heart failure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17306621     DOI: 10.1016/j.ejheart.2006.12.008

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  9 in total

Review 1.  Role of estrogen in diastolic dysfunction.

Authors:  Zhuo Zhao; Hao Wang; Jewell A Jessup; Sarah H Lindsey; Mark C Chappell; Leanne Groban
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-10       Impact factor: 4.733

Review 2.  NADPH oxidases in lung health and disease.

Authors:  Karen Bernard; Louise Hecker; Tracy R Luckhardt; Guangjie Cheng; Victor J Thannickal
Journal:  Antioxid Redox Signal       Date:  2014-01-03       Impact factor: 8.401

Review 3.  Cardiac remodeling in obesity.

Authors:  E Dale Abel; Sheldon E Litwin; Gary Sweeney
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

4.  Prevalence and prognostic impact of apical sparing contractility pattern in patients with aortic stenosis referred for transcatheter aortic valve implantation.

Authors:  Vera V Ferreira; Sílvia A Rosa; Tiago Pereira-da-Silva; Inês Rodrigues; António V Gonçalves; Tiago Mendonça; Alexandra Castelo; Luísa M Branco; Ana Galrinho; António Fiarresga; Ruben Ramos; Lino Patrício; Duarte Cacela; Rui C Ferreira
Journal:  Am J Cardiovasc Dis       Date:  2021-06-15

5.  Deletion of inducible nitric oxide synthase provides cardioprotection in mice with 2-kidney, 1-clip hypertension.

Authors:  Ying Sun; Oscar A Carretero; Jiang Xu; Nour-Eddine Rhaleb; James J Yang; Patrick J Pagano; Xiao-Ping Yang
Journal:  Hypertension       Date:  2008-11-10       Impact factor: 10.190

6.  Congenic expression of tissue inhibitor of metalloproteinase in Dahl-salt sensitive hypertensive rats is associated with reduced LV hypertrophy.

Authors:  Walter E Rodriguez; Neetu Tyagi; Alan Y Deng; Aso Adeagbo; Irving G Joshua; Suresh C Tyagi
Journal:  Arch Physiol Biochem       Date:  2008-12       Impact factor: 4.076

7.  Copper chelation in patients with hypertrophic cardiomyopathy.

Authors:  Anna Reid; Christopher Miller; John Peter Farrant; Rahul Polturi; David Clark; Simon Ray; Garth Cooper; Matthias Schmitt
Journal:  Open Heart       Date:  2022-02

Review 8.  Contribution of Oxidative Stress (OS) in Calcific Aortic Valve Disease (CAVD): From Pathophysiology to Therapeutic Targets.

Authors:  Daniela Maria Tanase; Emilia Valasciuc; Evelina Maria Gosav; Mariana Floria; Claudia Florida Costea; Nicoleta Dima; Ionut Tudorancea; Minela Aida Maranduca; Ionela Lacramioara Serban
Journal:  Cells       Date:  2022-08-27       Impact factor: 7.666

9.  Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone.

Authors:  Brooke C Henderson; Utpal Sen; Corey Reynolds; Karni S Moshal; Alexander Ovechkin; Neetu Tyagi; Ganesh K Kartha; Walter E Rodriguez; Suresh C Tyagi
Journal:  Int J Biol Sci       Date:  2007-09-07       Impact factor: 6.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.